AKTX · Akari Therapeutics Plc
$8.46
-0.24 (-2.70%)
At close · Jul 27
Going-concern doubt
— flagged May 19, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company’s ability to continue as a going concern for at least a one-year period following the issuance of these condensed consolidated financial statements.”View the 10-Q filed May 19, 2026
Market Cap
$14.81M
Shares
1.75M
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2026-06-03 | New | Other Health Care | $5,500,000 | $1,833,333 | 06b |
| 2025-10-24 | New | Other Health Care | $6,250,000 | $6,250,000 | 06b |
| 2024-01-09 | New | Other Health Care | $2,000,001 | $2,000,001 | 06b |
| 2023-10-19 | New | Other Health Care | $1,971,001 | $1,971,001 | 06c |
| 2022-09-27 | New | Biotechnology | $12,835,000 | $12,835,000 | 06b |
| 2021-07-22 | New | Biotechnology | $12,318,688 | $12,318,688 | 06b |
| 2020-03-11 | New | Biotechnology | $9,554,528 | $9,554,528 | 06b |
Showing 1–7 of 7 filings